TrialDrug design, development and therapy2023

Phase I, Single-Dose Study to Assess the Pharmacokinetics and Safety of Suramin in Healthy Chinese Volunteers.

Guolan Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.